What is the purpose of this test?
The Morgan Prenatal Blood Test Panel #1 is designed to check important health factors during pregnancy. It includes a Hepatitis B Surface Antigen test to screen for hepatitis B, which can be passed from mother to baby during childbirth. Knowing if a mother has hepatitis B allows doctors to take steps to protect the baby from infection. The panel also includes ABO Grouping and RH Typing, which determine the mother's blood type and Rh factor. This is important because if the mother's Rh factor is negative and the baby’s is positive, it could lead to complications during pregnancy.
Additionally, the panel tests for Rubella IgG antibodies, which show if the mother is immune to rubella, a virus that can cause serious birth defects if contracted during pregnancy. By checking these key factors, the test helps ensure that both the mother and baby are healthy and that any potential issues are addressed early in the pregnancy.
The Morgan Prenatal Blood Test Panel #1 includes the following:
- ABO Group and RHO(D) Typing - are blood tests that determine an individual's blood type (A, B, AB, or O) and the presence of the Rh factor (positive or negative). Their significance to prenatal health lies in ensuring compatibility between the mother and fetus; incompatible blood types can lead to complications during pregnancy, such as hemolytic disease of the newborn. Knowing these blood types helps healthcare providers manage pregnancies more effectively and prevent potential risks to both the mother and baby.
- Rubella Antibodies IgG - is a blood test that measures the presence of IgG antibodies against the rubella virus, indicating whether a person has been vaccinated or previously infected. Its significance to prenatal health lies in assessing a pregnant woman's immunity to rubella, which can cause serious birth defects if contracted during pregnancy. Knowing a woman’s rubella immunity status helps healthcare providers take necessary precautions to protect the fetus and ensure a healthy pregnancy.
- Hepatitis B Surface Antigen - is a blood test that detects the presence of the hepatitis B virus in the body. Its significance to prenatal health lies in identifying whether a pregnant woman is infected with hepatitis B, which can be transmitted to the baby during childbirth. Early detection allows healthcare providers to implement preventive measures, such as vaccination for the newborn and antiviral treatments for the mother, to reduce the risk of transmission and ensure the health of both mother and child.
Benefits of the Morgan Prenatal Blood Test Panel #1:
- Hepatitis B Screening: Identifies Hepatitis B infection to protect mother and baby.
- ABO Grouping: Determines blood type for potential transfusion needs.
- RH Typing: Assesses Rh factor to prevent complications during pregnancy.
- Rubella Immunity: Checks for immunity to rubella, reducing infection risks.
- Early Detection: Facilitates early identification of potential health issues.
- Informed Care: Helps healthcare providers make informed prenatal decisions.
- Convenient Testing: Easy access to essential prenatal tests through Walk-In Lab.
Test Code(s):
1610, 24030
Preparation:
Patient should maintain a stable diet for 2–3 weeks before blood collection and fast for 12–14 hours prior. Stop biotin 72 hours before collection.
Test Results:
2-3 days. May take longer based on weather, holiday, or lab delays.
